# Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial

> **NCT05500469** · NA · RECRUITING · sponsor: **Oogziekenhuis Rotterdam** · enrollment: 200 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** Paul glaucoma drainage device (GDD)

## Key facts

- **NCT ID:** NCT05500469
- **Lead sponsor:** Oogziekenhuis Rotterdam
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-20
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05500469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05500469, "Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05500469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*